Home | Welcome to Contract Pharma   
Last Updated Saturday, May 25 2013
Print

Industry News

Related Searches:

Filter by:

March 14, 2012
Will complete full commercial manufacture of DuoCort’s Plenadren   Read More »
March 14, 2012
Will develop a generic copy for small-scale production   Read More »
March 13, 2012
Will provide commercial manufacture of talactoferrin   Read More »
March 13, 2012
Adds instrumentation and increased analytical capabilities   Read More »
March 13, 2012
Offers enhanced new language capabilities and data integration   Read More »
March 13, 2012
Adds 12,000 sq.-ft. of space for validation, packaging testing   Read More »
March 12, 2012
Invests more than £500k in new vial filling equipment   Read More »
March 9, 2012
Augments Mumbai capabilities   Read More »
March 9, 2012
Invests $22 million in development and manufacturing capabilities   Read More »
March 8, 2012
Will offer bioavailability solutions to clients   Read More »
March 8, 2012
Adds capabilities in North America and Europe   Read More »
March 8, 2012
Gains Phase I drug and Avilomics discovery platform   Read More »
March 8, 2012
Will provide manufacturing, registration, and validation services   Read More »
March 7, 2012
Completes German warehousing and controlled substance expansion   Read More »
March 7, 2012
Adds 100,000-sq.-ft. commercial facility in Audubon, PA   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On